A bio-tech company shaping the future of marine antifouling coatings

We are the developers of Selektope - an active antifouling agent that repels barnacles from ships.

This is I-Tech AB

I-Tech is a Nasdaq First North Growth Market-listed bio-technology company [TICKER:ITECH] based in  Sweden. We develop, market and sell the performance ingredient, Selektope® for use in marine antifouling coatings.

Our vision is to establish Selektope® as the leading technology to prohibit marine growth in an effective and sustainable way.

About I-Tech
CORPORATE CONTACTS
Markus 272 × 232

Markus Jönsson

CEO
markus.jonsson@i-tech.se

Magnus Henell

Magnus Henell

CFO & Head of Operations
magnus.henell@i-tech.se

Monica 272 × 232

Monica Kettelhoit

Office Manager
monica.kettelhoit@i-tech.se

Jennifer Ardin, Marketing, Brand and Relations Manager (2) (1)

Jennifer Ardin

Marketing, Brand & Relations Manager
jennifer.ardin@i-tech.se

Selektope logo light

Its powerful, repellent effect on barnacles keeps the ship's hull clean.

Visit selektope.com
Latest news

Show all

2025

2025-08-22 08:00 I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2025 Regulatory MAR
I-Tech’s CEO, Markus Jönsson and I-Tech’s CFO & Director Operations, Magnus Henell will present...
2025-06-13 15:30 I-Tech announces outcome of warrant exercise Regulatory
I-Tech AB (publ) announces the successful exercise of warrants from the 2022/2025 series. The program...
2025-05-23 13:40 I-Tech announces a one year extension of the current EU Approval for Selektope (Medetomidine)
I-Tech AB, developers of the innovative antifouling technology Selektope, announce that the current approval...

Selektope® - ECHA Consultation: Thank you for contributing

We have reached the final submission date of the public consultation to protect our waterways and ensure a sustainable future.

We are grateful for the huge amount of support.

Read more

The European Chemicals Agency (ECHA) is an agency of the EU working for the safe use of chemicals. Biocides are approved by stringent regulatory schemes across different geographies. In the EU, all biocides undergo an extensive approval process under the EU Biocidal Products Regulation.

ECHA is considering the renewal of Medetomidine, the crucial component of our antifouling product, Selektope. If not approved, Selektope's future in the EU market is at risk.

Next Conference
International antifouling conference 2025 (1)
Learn more
Latest Presentation

Show all

August 22, 2025

Q2 2025, Webcast

CEO Markus Jönsson and CFO & Director of Operations Magnus Henell will present the Q2 2025 report and take part in a live Q&A session with the audience.

(22 minutes, English)

Investor Communications

Sign up here to get the latest press releases and financial reports from I-Tech AB directly to your inbox.